Studies related to Esophageal Cancer Risk and Garlic

Fifteen-year Effects Of Helicobacter Pylori, Garlic, And Vitamin Treatments On Gastric Cancer Incidence And Mortality

Effect None
Trial Design Cohort
Trial Length 6+ Months
Number of Subjects 3365
Sex Both Genders
Notes for this study:
In a followup study where garlic was used for 7.3 years and failed to reduce precancerous lesions of the stomach, 7.3 years later participants were noted to have a nonsignificant reduction in stomach cancer and esophageal cancer and mortality risk associated with garlic therapy.